VKH
NMTR

Virtu KCG Holdings’s 9 Meters Biopharma NMTR Stock Holding History

Virtu KCG Holdings’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$32K Buy
330
+220
+200% +$30.7K ﹤0.01% 2670
2017
Q1 		$26K Sell
110
-16
-13% -$4.8K ﹤0.01% 2947
2016
Q4 		$44K Buy
+126
New +$36.5K ﹤0.01% 3113

Other funds holding NMTR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Virtu KCG Holdings's NMTR Position: Q2 2017 in Review

Virtu KCG Holdings increased its 9 Meters Biopharma (NMTR) stake by 200% in Q2 2017, buying an estimated $30.7K and bringing the position to 330 shares worth $32K. The position accounts for ﹤0.01% of the portfolio, ranked #2670.

Virtu KCG Holdings first reported a position in NMTR in Q4 2016 and has held it in 3 quarters since. The position peaked at $44K in Q4 2016. 7 funds tracked by Wall St. Rank hold NMTR as of Q2 2017.

  • Virtu KCG Holdings held 330 shares of 9 Meters Biopharma worth $32K as of Q2 2017.
  • Virtu KCG Holdings bought 220 9 Meters Biopharma shares in Q2 2017, an estimated $30.7K.
  • 9 Meters Biopharma made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2670 holding.
  • Virtu KCG Holdings first reported a position in 9 Meters Biopharma in Q4 2016 and has held it in 3 quarters since.
  • Virtu KCG Holdings's 9 Meters Biopharma position peaked at $44K in Q4 2016.
  • 7 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.